Demonstrates that phosphorylation of eNOS at serine 1179 is essential for regulating basal and stimulated NO release and endothelium-dependent vasomotion.
Authors
No takes yet. Share an insight, caveat, or question.
Caution against clinical extrapolation from mouse data; leaves open therapeutic targeting of eNOS Ser1179 in human vascular disease.
Scotland et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: